Benjamin L.L. Clayton

1.4k total citations
18 papers, 951 citations indexed

About

Benjamin L.L. Clayton is a scholar working on Molecular Biology, Developmental Neuroscience and Neurology. According to data from OpenAlex, Benjamin L.L. Clayton has authored 18 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Developmental Neuroscience and 6 papers in Neurology. Recurrent topics in Benjamin L.L. Clayton's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and MicroRNA in disease regulation (5 papers). Benjamin L.L. Clayton is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and MicroRNA in disease regulation (5 papers). Benjamin L.L. Clayton collaborates with scholars based in United States, South Korea and Canada. Benjamin L.L. Clayton's co-authors include Brian Popko, Paul J. Tesar, Richard P. Kraig, Aya D. Pusic, Kae M. Pusic, Robert H. Miller, Mayur Madhavan, Kevin Allan, H. Elizabeth Shick and Lilianne Barbar and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Nature Neuroscience.

In The Last Decade

Benjamin L.L. Clayton

18 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin L.L. Clayton United States 13 597 236 182 180 162 18 951
Ginez A. González United Kingdom 9 368 0.6× 237 1.0× 59 0.3× 163 0.9× 150 0.9× 11 765
Devon S. Svoboda Canada 9 784 1.3× 205 0.9× 110 0.6× 165 0.9× 66 0.4× 13 1.2k
Ken‐ichi Mizutani Japan 14 604 1.0× 338 1.4× 137 0.8× 61 0.3× 83 0.5× 28 979
Olatz Pampliega United States 13 743 1.2× 81 0.3× 113 0.6× 197 1.1× 208 1.3× 14 1.5k
Jeong‐Sun Choi South Korea 21 418 0.7× 144 0.6× 80 0.4× 211 1.2× 45 0.3× 37 943
Sandrine Willaime‐Morawek United Kingdom 16 493 0.8× 142 0.6× 60 0.3× 73 0.4× 74 0.5× 26 846
Gianluca Figlia Germany 15 475 0.8× 153 0.6× 127 0.7× 52 0.3× 131 0.8× 17 847
Guoping Liu China 19 774 1.3× 197 0.8× 410 2.3× 136 0.8× 42 0.3× 43 1.3k
Martina Gabrielli Italy 16 1.2k 1.9× 116 0.5× 471 2.6× 550 3.1× 87 0.5× 24 1.6k
Chia-Yi Kuan United States 19 402 0.7× 117 0.5× 72 0.4× 257 1.4× 103 0.6× 37 981

Countries citing papers authored by Benjamin L.L. Clayton

Since Specialization
Citations

This map shows the geographic impact of Benjamin L.L. Clayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L.L. Clayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L.L. Clayton more than expected).

Fields of papers citing papers by Benjamin L.L. Clayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L.L. Clayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L.L. Clayton. The network helps show where Benjamin L.L. Clayton may publish in the future.

Co-authorship network of co-authors of Benjamin L.L. Clayton

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin L.L. Clayton. A scholar is included among the top collaborators of Benjamin L.L. Clayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin L.L. Clayton. Benjamin L.L. Clayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tesar, Paul J., et al.. (2025). Astrocyte and oligodendrocyte pathology in Alzheimer's disease. Neurotherapeutics. 22(3). e00540–e00540. 4 indexed citations
2.
Clayton, Benjamin L.L. & Shane A. Liddelow. (2025). Heterogeneity of Astrocyte Reactivity. Annual Review of Neuroscience. 48(1). 231–249. 4 indexed citations
3.
Clayton, Benjamin L.L., Mayur Madhavan, Yuriy Fedorov, et al.. (2024). Pervasive environmental chemicals impair oligodendrocyte development. Nature Neuroscience. 27(5). 836–845. 24 indexed citations
4.
Clayton, Benjamin L.L., Kevin Allan, Molly Karl, et al.. (2024). A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. Nature Neuroscience. 27(4). 656–665. 13 indexed citations
5.
Clayton, Benjamin L.L., Lilianne Barbar, Maria L. Sapar, et al.. (2024). Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis. Cell stem cell. 31(11). 1701–1713.e8. 12 indexed citations
6.
Clayton, Benjamin L.L. & Paul J. Tesar. (2021). Oligodendrocyte progenitor cell fate and function in development and disease. Current Opinion in Cell Biology. 73. 35–40. 41 indexed citations
7.
Allan, Kevin, Marissa A. Scavuzzo, Andrew R. Morton, et al.. (2020). Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function. Cell stem cell. 28(2). 257–272.e11. 33 indexed citations
8.
Baldassari, Laura, Benjamin L.L. Clayton, Se‐Hong Oh, et al.. (2019). Developing therapeutic strategies to promote myelin repair in multiple sclerosis. Expert Review of Neurotherapeutics. 19(10). 997–1013. 19 indexed citations
9.
Madhavan, Mayur, Zachary S. Nevin, H. Elizabeth Shick, et al.. (2018). Induction of myelinating oligodendrocytes in human cortical spheroids. Nature Methods. 15(9). 700–706. 240 indexed citations
10.
Lager, Angela M., Olivia Corradin, Jared M. Cregg, et al.. (2018). Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells. Nature Communications. 9(1). 3708–3708. 17 indexed citations
11.
Elitt, Matthew S., H. Elizabeth Shick, Mayur Madhavan, et al.. (2018). Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease. Stem Cell Reports. 11(3). 711–726. 27 indexed citations
12.
Clayton, Benjamin L.L., Aaron Huang, Rejani B. Kunjamma, Ani Solanki, & Brian Popko. (2017). The Integrated Stress Response in Hypoxia-Induced Diffuse White Matter Injury. Journal of Neuroscience. 37(31). 7465–7480. 7 indexed citations
13.
Clayton, Benjamin L.L., et al.. (2017). Neonatal Hypoxia Results in Peripheral Nerve Abnormalities. American Journal Of Pathology. 187(2). 245–251. 5 indexed citations
14.
Rossi, Pierre De, Virginie Buggia-Prévot, Benjamin L.L. Clayton, et al.. (2016). Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Molecular Neurodegeneration. 11(1). 59–59. 87 indexed citations
15.
Clayton, Benjamin L.L. & Brian Popko. (2016). Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia. Brain Research. 1648(Pt B). 594–602. 69 indexed citations
16.
Way, Sharon W., Joseph R. Podojil, Benjamin L.L. Clayton, et al.. (2015). Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nature Communications. 6(1). 6532–6532. 93 indexed citations
17.
Pusic, Aya D., Kae M. Pusic, Benjamin L.L. Clayton, & Richard P. Kraig. (2013). IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. Journal of Neuroimmunology. 266(1-2). 12–23. 160 indexed citations
18.
Lin, Wensheng, Yifeng Lin, Jin Li, et al.. (2013). Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis. Journal of Neuroscience. 33(14). 5980–5991. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ginez A. González Breakdown of academic impact, for papers by Devon S. Svoboda Breakdown of academic impact, for papers by Ken‐ichi Mizutani Breakdown of academic impact, for papers by Olatz Pampliega Breakdown of academic impact, for papers by Jeong‐Sun Choi Breakdown of academic impact, for papers by Sandrine Willaime‐Morawek Breakdown of academic impact, for papers by Gianluca Figlia Breakdown of academic impact, for papers by Guoping Liu Breakdown of academic impact, for papers by Martina Gabrielli Breakdown of academic impact, for papers by Chia-Yi Kuan
Rankless by CCL
2026